PCPE-1 inhibitors are chemical entities that target the enzyme procollagen C-proteinase enhancer 1 (PCPE-1), which is known to interact with and enhance the activity of procollagen C-proteinases, particularly BMP-1, which are involved in the processing of procollagens into mature collagens. These inhibitors include a variety of compounds, most of which are characterized as metalloproteinase inhibitors. Typically, these inhibitors function by binding to the zinc ion within the active site of PCPE-1, thereby its interaction with procollagen or interfering with its activity.
PCPE-1 inhibitors primarily consists of small molecule inhibitors, hydroxamates, and chelating agents. These inhibitors typically possess functional groups that allow them to coordinate with the zinc ion in the active site of PCPE-1, which is crucial for the enzyme's activity. The binding of these inhibitors to the zinc ion effectively the conformational changes and substrate interactions necessary for PCPE-1's role in procollagen processing. As such, these inhibitors can act as effective agents in disrupting the function of PCPE-1. Additionally, some PCPE-1 inhibitors belong to the class of peptide antibiotics or are structures designed to inhibit a broad spectrum of matrix metalloproteinases, exploiting similarities in catalytic mechanisms among metalloproteases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Metalloproteinase inhibitor that binds to the zinc ion in the active site, preventing PCPE-1 from interacting with procollagen. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Broad-spectrum matrix metalloproteinase inhibitor that can also inhibit PCPE-1 by chelating the zinc ion in its active site. | ||||||
Prinomastat | 192329-42-3 | sc-507449 | 5 mg | $190.00 | ||
Designed to inhibit matrix metalloproteinases, prinomastat may inhibit PCPE-1 due to similarity in mechanism, by binding to the metal ion in the enzyme. | ||||||
Actinonin | 13434-13-4 | sc-201289 sc-201289B | 5 mg 10 mg | $170.00 $385.00 | 3 | |
Peptide antibiotic that inhibits metalloproteases; could bind to PCPE-1 and inhibit its enzymatic activity. | ||||||
1,10-Phenanthroline | 66-71-7 | sc-255888 sc-255888A | 2.5 g 5 g | $23.00 $32.00 | ||
Metal chelator with the ability to inhibit metalloenzymes; can bind to zinc in PCPE-1, leading to inhibition. | ||||||
Atrasentan Hydrochloride | 195733-43-8 | sc-503157 | 50 mg | $490.00 | ||
Inhibitor of necrosis factor-alpha converting enzyme, and may inhibit PCPE-1 by similar mechanisms of metalloprotease inhibition. | ||||||